Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma [version 1; referees: 2 approved]
Follicular lymphoma (FL) is the most common type of indolent B-cell lymphoma. Twenty years ago, FL was considered an indolent lymphoma with a long survival time but without a high rate of complete remission with chemotherapies. The use of rituximab has improved the response and survival of patients...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2019-03-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/8-294/v1 |